These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 35731316)

  • 1. Missense mutation in ATXN2 gene (c.2860C > T) in an amyotrophic lateral sclerosis patient with aggressive disease phenotype.
    Ghezzi A; Martinelli I; Carra S; Mediani L; Zucchi E; Simonini C; Gianferrari G; Fini N; Cereda C; Gellera C; Pensato V; Mandrioli J
    Neurol Sci; 2022 Oct; 43(10):6087-6090. PubMed ID: 35731316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Motor neurone disease/amyotrophic lateral sclerosis associated with intermediate-length CAG repeat expansions in Ataxin-2 does not have 1C2-positive polyglutamine inclusions.
    Highley JR; Lorente Pons A; Cooper-Knock J; Wharton SB; Ince PG; Shaw PJ; Wood J; Kirby J
    Neuropathol Appl Neurobiol; 2016 Jun; 42(4):377-89. PubMed ID: 26095883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intermediate-length CAG repeat in ATXN2 is associated with increased risk for amyotrophic lateral sclerosis in Brazilian patients.
    Tavares de Andrade HM; Cintra VP; de Albuquerque M; Piccinin CC; Bonadia LC; Duarte Couteiro RE; Sabino de Oliveira D; Claudino R; Magno Gonçalves MV; Dourado MET; de Souza LC; Teixeira AL; de Godoy Rousseff Prado L; Tumas V; Bulle Oliveira AS; Nucci A; Lopes-Cendes I; Marques W; França MC
    Neurobiol Aging; 2018 Sep; 69():292.e15-292.e18. PubMed ID: 29934271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of ATXN2 trinucleotide repeats in Korean patients with amyotrophic lateral sclerosis.
    Kim YE; Oh KW; Noh MY; Park J; Kim HJ; Park JE; Ki CS; Kim SH
    Neurobiol Aging; 2018 Jul; 67():201.e5-201.e8. PubMed ID: 29665996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebellar neuronal loss in amyotrophic lateral sclerosis cases with ATXN2 intermediate repeat expansions.
    Tan RH; Kril JJ; McGinley C; Hassani M; Masuda-Suzukake M; Hasegawa M; Mito R; Kiernan MC; Halliday GM
    Ann Neurol; 2016 Feb; 79(2):295-305. PubMed ID: 26599997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ATXN2 trinucleotide repeat length correlates with risk of ALS.
    Sproviero W; Shatunov A; Stahl D; Shoai M; van Rheenen W; Jones AR; Al-Sarraj S; Andersen PM; Bonini NM; Conforti FL; Van Damme P; Daoud H; Del Mar Amador M; Fogh I; Forzan M; Gaastra B; Gellera C; Gitler AD; Hardy J; Fratta P; La Bella V; Le Ber I; Van Langenhove T; Lattante S; Lee YC; Malaspina A; Meininger V; Millecamps S; Orrell R; Rademakers R; Robberecht W; Rouleau G; Ross OA; Salachas F; Sidle K; Smith BN; Soong BW; Sorarù G; Stevanin G; Kabashi E; Troakes C; van Broeckhoven C; Veldink JH; van den Berg LH; Shaw CE; Powell JF; Al-Chalabi A
    Neurobiol Aging; 2017 Mar; 51():178.e1-178.e9. PubMed ID: 28017481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ATXN2 is a modifier of phenotype in ALS patients of Sardinian ancestry.
    Borghero G; Pugliatti M; Marrosu F; Marrosu MG; Murru MR; Floris G; Cannas A; Parish LD; Cau TB; Loi D; Ticca A; Traccis S; Manera U; Canosa A; Moglia C; Calvo A; Barberis M; Brunetti M; Renton AE; Nalls MA; Traynor BJ; Restagno G; Chiò A;
    Neurobiol Aging; 2015 Oct; 36(10):2906.e1-5. PubMed ID: 26208502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ATXN2-AS, a gene antisense to ATXN2, is associated with spinocerebellar ataxia type 2 and amyotrophic lateral sclerosis.
    Li PP; Sun X; Xia G; Arbez N; Paul S; Zhu S; Peng HB; Ross CA; Koeppen AH; Margolis RL; Pulst SM; Ashizawa T; Rudnicki DD
    Ann Neurol; 2016 Oct; 80(4):600-15. PubMed ID: 27531668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intermediate-length polyglutamine in ATXN2 is a possible risk factor among Eastern Chinese patients with amyotrophic lateral sclerosis.
    Lu HP; Gan SR; Chen S; Li HF; Liu ZJ; Ni W; Wang N; Wu ZY
    Neurobiol Aging; 2015 Mar; 36(3):1603.e11-4. PubMed ID: 25457026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ATXN2 CAG repeat expansions increase the risk for Chinese patients with amyotrophic lateral sclerosis.
    Liu X; Lu M; Tang L; Zhang N; Chui D; Fan D
    Neurobiol Aging; 2013 Sep; 34(9):2236.e5-8. PubMed ID: 23635656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C9orf72 and ATXN2 repeat expansions coexist in a family with ataxia, dementia, and parkinsonism.
    Zhang M; Xi Z; Misquitta K; Sato C; Moreno D; Liang Y; Slow E; Rogaeva E; Tartaglia MC
    Mov Disord; 2017 Jan; 32(1):158-162. PubMed ID: 28124431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ATXN2 intermediate repeat expansions influence the clinical phenotype in frontotemporal dementia.
    Rubino E; Mancini C; Boschi S; Ferrero P; Ferrone M; Bianca S; Zucca M; Orsi L; Pinessi L; Govone F; Vacca A; Gai A; Giordana MT; Brusco A; Rainero I
    Neurobiol Aging; 2019 Jan; 73():231.e7-231.e9. PubMed ID: 30342763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C9orf72 hexanucleotide repeat expansions and Ataxin 2 intermediate length repeat expansions in Indian patients with amyotrophic lateral sclerosis.
    Narain P; Gomes J; Bhatia R; Singh I; Vivekanandan P
    Neurobiol Aging; 2017 Aug; 56():211.e9-211.e14. PubMed ID: 28527524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ATNX2 is not a regulatory gene in Italian amyotrophic lateral sclerosis patients with C9ORF72 GGGGCC expansion.
    Chiò A; Mora G; Sabatelli M; Caponnetto C; Lunetta C; Traynor BJ; Johnson JO; Nalls MA; Calvo A; Moglia C; Borghero G; Trojsi F; La Bella V; Volanti P; Simone I; Salvi F; Logullo FO; Riva N; Carrera P; Giannini F; Mandrioli J; Tanel R; Capasso M; Tremolizzo L; Battistini S; Murru MR; Origone P; Zollino M; Penco S; ; ; Mazzini L; D'Alfonso S; Restagno G; Brunetti M; Barberis M; Conforti FL
    Neurobiol Aging; 2016 Mar; 39():218.e5-8. PubMed ID: 26733254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous ALS and SCA2 associated with an intermediate-length
    Ghahremani Nezhad H; Franklin JP; Alix JJP; Moll T; Pattrick M; Cooper-Knock J; Shanmugarajah P; Beauchamp NJ; Hadjivissiliou M; Paling D; Mcdermott C; Shaw PJ; Jenkins TM
    Amyotroph Lateral Scler Frontotemporal Degener; 2021 Nov; 22(7-8):579-582. PubMed ID: 33284045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PolyQ repeat expansions in ATXN2 associated with ALS are CAA interrupted repeats.
    Yu Z; Zhu Y; Chen-Plotkin AS; Clay-Falcone D; McCluskey L; Elman L; Kalb RG; Trojanowski JQ; Lee VM; Van Deerlin VM; Gitler AD; Bonini NM
    PLoS One; 2011 Mar; 6(3):e17951. PubMed ID: 21479228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyotrophic lateral sclerosis risk for spinocerebellar ataxia type 2 ATXN2 CAG repeat alleles: a meta-analysis.
    Neuenschwander AG; Thai KK; Figueroa KP; Pulst SM
    JAMA Neurol; 2014 Dec; 71(12):1529-34. PubMed ID: 25285812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of ATXN2 intermediate-length CAG repeats with amyotrophic lateral sclerosis correlates with the distributions of normal CAG repeat alleles among individual ethnic populations.
    Naruse H; Matsukawa T; Ishiura H; Mitsui J; Takahashi Y; Takano H; Goto J; Toda T; Tsuji S
    Neurogenetics; 2019 May; 20(2):65-71. PubMed ID: 30847648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intermediate CAG repeat expansion in the ATXN2 gene is a unique genetic risk factor for ALS--a systematic review and meta-analysis of observational studies.
    Wang MD; Gomes J; Cashman NR; Little J; Krewski D
    PLoS One; 2014; 9(8):e105534. PubMed ID: 25148523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ATXN2 intermediate expansions in amyotrophic lateral sclerosis.
    Glass JD; Dewan R; Ding J; Gibbs JR; Dalgard C; Keagle PJ; Shankaracharya ; García-Redondo A; Traynor BJ; Chia R; Landers JE
    Brain; 2022 Aug; 145(8):2671-2676. PubMed ID: 35521889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.